Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II.
about
UPR-induced resistance to etoposide is downstream of PERK and independent of changes in topoisomerase IIα levelsPhase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology GroupA Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium ReportAutocrine growth factors and solid tumor malignancy.Decreased expression of insulin-like growth factor binding protein 6 is associated with gastric adenocarcinoma prognosis.IGF-II dependent autocrine growth in cell lines derived from renal tumours of childhood.IGF2 promotes growth of adrenocortical carcinoma cells, but its overexpression does not modify phenotypic and molecular features of adrenocortical carcinoma.The effects of growth hormone and IGF-1 deficiency on cerebrovascular and brain ageing.Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma.The role of the insulin-like growth factor system in adrenocortical tumourigenesis.Insulin-like growth factor II-mediated proliferation of human neuroblastoma.Models of growth hormone and IGF-1 deficiency: applications to studies of aging processes and life-span determination.Insulin-like growth factors act synergistically with basic fibroblast growth factor and nerve growth factor to promote chromaffin cell proliferation.Enhanced efficacy of IGF1R inhibition in pediatric glioblastoma by combinatorial targeting of PDGFRα/β.Combination testing (Stage 2) of the Anti-IGF-1 receptor antibody IMC-A12 with rapamycin by the pediatric preclinical testing program.Interleukins and neurohormones: a common language.Plasticity of neuroblastoma tumor cells to differentiate along a fetal adrenal ganglionic lineage predicts for improved patient survival.Neuroblastoma in the very young child: biological considerations.Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cellsIGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma.Insulin-like growth factor II in the pathogenesis of human neuroblastoma.Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factorExpression of transforming growth factor-beta isoforms in small round cell tumors of childhood. An immunohistochemical studyPhase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group.Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alphaDisruption of the MyoD/p21 Pathway in RhabdomyosarcomaAutocrine Transforming Growth Factor-beta Growth Pathway in Murine Osteosarcoma Cell Lines Associated with Inability to Affect Phosphorylation of Retinoblastoma Protein.Low Dose Histone Deacetylase Inhibitor, Depsipeptide (FR901228), Promotes Adenoviral Transduction in Human Rhabdomyosarcoma Cell LinesThe role of IGF-1R in pediatric malignancies.Pharmacotherapy of neuroblastoma.Down-regulation of achaete-scute complex homolog 1 (ASCL1) in neuroblastoma cells induces up-regulation of insulin-like growth factor 2 (IGF2).Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumour clone.IGF-I stimulates proliferation of spontaneously immortalized human keratinocytes (HACAT) by autocrine/paracrine mechanisms.Expression of insulin-like growth factor-binding protein 5 in neuroblastoma cells is regulated at the transcriptional level by c-Myb and B-Myb via direct and indirect mechanisms.Diminished G1 checkpoint after gamma-irradiation and altered cell cycle regulation by insulin-like growth factor II overexpression.IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity.Apoptosis of N-type neuroblastoma cells after differentiation with 9-cis-retinoic acid and subsequent washout.Structural analysis of the human insulin-like growth factor-II P3 promoter.Insulin-like growth factor-1 and childhood cancer risk.Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer.
P2860
Q28484607-0F45B550-FDE9-4085-92D7-8926022101B7Q33398810-8DD76AC8-DFCE-446E-83C2-3C1E22B4C9F7Q33419115-CA59E895-28F0-491F-A5F8-778D0A0B8514Q33559452-0F26D2E8-0F3B-4E81-95BF-E46CFC4CCDD9Q33750793-E743001B-0802-4FCB-81EF-3B615B90A583Q33839585-5BC15358-B0BC-4F92-ACB4-691AE110A5E4Q33999643-54022C3F-60E4-4243-9611-09986A46D39CQ34150795-723446B2-0502-4A49-8F50-3459D03E2D47Q34185775-13A102A5-C466-4D43-AE4C-381D5E25CE1CQ34204050-1F33C713-C89C-404F-9F7E-8F17907C6128Q34237722-EB33625B-A1DB-4E21-934D-A200743A58B7Q34620251-C01854D2-FA4B-41F2-A19E-BC67CFEE6FA0Q35073054-EFDDF9AD-87E3-48E6-99BA-B65FCE1CDDECQ35177853-60A36E79-AE31-42C6-903B-A69D3ED95835Q35194644-FAF025F3-BF3A-4B55-9A35-439E3C8320DAQ35236180-C12EA8B9-51F4-419E-B5D0-6352177757F6Q35613532-77BF1352-1D0B-4877-A609-D157E00F5A1FQ35708386-66C3B2D3-4101-46DD-8E8B-85EFBA4F385AQ35788080-D032821B-EEFA-44D3-8D43-C53CA3FFD491Q35794996-9019BB03-0649-4033-B071-9930596FCC05Q35796432-7EC2758C-7E4B-45D1-BDA0-FF33C4DCF32DQ35816926-2D2F8A69-044E-4B5E-99A9-56D303069F8BQ35832578-898B348A-F40C-4B67-B575-1DEDB083316FQ35880614-4BD16E12-3AB2-4B71-8056-A55EF7ECE19FQ35993625-F7547CB0-CD09-4984-BD70-C83DDCB18A7AQ36673846-7CB4A13E-B536-4769-84EE-205E41A28D6EQ36674035-DB16DECE-A783-4B0C-A98A-969513F19232Q36674393-73B7C7DE-569A-4AC4-A536-1B6EBF0714AAQ37290912-09B1063E-68F7-4AFC-A164-7075A9E52188Q37735199-E7DA8764-5BE4-45D4-9F09-8316F8D7A588Q39655788-A0A2994F-959E-4CDE-9207-18D9F0F83E23Q39709152-1982DB79-7192-4207-8497-2DD083BF7983Q40558607-7A115B30-032E-426F-A027-98F9512ED8D9Q40735954-7F4F9CFE-74E9-44AE-B01F-68090EFF5B53Q40957469-4F60622F-2C75-48A3-95A4-ABB57B0150ACQ41013044-D91E31E0-1F6A-4988-9FED-A0FAB52F597AQ41120397-E3FFCC0D-D3A0-44E6-93A6-691C3E6BEF0EQ41844735-221D4F50-1300-4B1E-9E04-117B0F6BC289Q41888993-5E3774D4-FE3C-48DD-AB82-203624C61F68Q43144913-9D139E2E-CE26-4B8D-909A-A26BC8A5E7AA
P2860
Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Autonomous growth of a human n ...... insulin-like growth factor II.
@ast
Autonomous growth of a human n ...... insulin-like growth factor II.
@en
type
label
Autonomous growth of a human n ...... insulin-like growth factor II.
@ast
Autonomous growth of a human n ...... insulin-like growth factor II.
@en
prefLabel
Autonomous growth of a human n ...... insulin-like growth factor II.
@ast
Autonomous growth of a human n ...... insulin-like growth factor II.
@en
P2093
P2860
P356
P1476
Autonomous growth of a human n ...... insulin-like growth factor II.
@en
P2093
P2860
P304
P356
10.1172/JCI114243
P407
P577
1989-09-01T00:00:00Z